Clincosm LogoSign in Get a demo

Small-cell Lung Cancer

Showing 1 - 25 of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Oligoprogressive, Small-cell Lung Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 27, 2023

Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for

Not yet recruiting
  • Carcinoma
  • +7 more
  • XNW5004
  • Pembrolizumab 25 mg/mL Solution for Injection
  • (no location specified)
Aug 31, 2023

Small-cell Lung Cancer Trial in Guangzhou (Serplulimab)

Recruiting
  • Small-cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong Provincial Perople's Hospital
Jul 20, 2023

Molecular Analysis and Treatment Options of SCLC

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Shanghai, China
    Shanghai Chest Hospital
Jul 6, 2023

Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal

Not yet recruiting
  • Esophagus Cancer
  • +4 more
  • Intravenous injection of P-IL-2
  • P-IL-2 plus Anti-PD-1 Monoclonal Antibody
  • (no location specified)
Apr 24, 2023

Lung Cancer, Small-cell Lung Cancer, Non Small Cell Lung Cancer Trial in Philadelphia (Carboplatin, Pemetrexed, Paclitaxel)

Recruiting
  • Lung Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 24, 2023

Durvalumab in Combination With Standard Chemotherapy of

Recruiting
  • Small-cell Lung Cancer
  • Extensive-stage Small-cell Lung Cancer
    • Néo Fáliro, Greece
      Metropolitan Hospital
    Mar 7, 2023

    RW Effectiveness of Lurbinectedin in Extensive Stage SCLC

    Completed
    • Small-cell Lung Cancer
    • Paris, France
    • +1 more
    Jan 5, 2023

    Advanced Solid Tumor, MSI-H/dMMR Tumors, Cutaneous Squamous Cell Carcinoma Trial in Worldwide (INCB099280)

    Recruiting
    • Advanced Solid Tumor
    • +11 more
    • Boston, Massachusetts
    • +30 more
    Dec 1, 2022

    Non Small Cell Lung Cancer, NSCLC, Small-cell Lung Cancer Trial in Saint Louis (ADI-PEG 20, Gemcitabine, Docetaxel)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • ADI-PEG 20
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 14, 2022

    Lung Cancer, Lung Cancer Metastatic, Brain Metastases Trial in United States (Stereotactic Radiosurgery, Cerebrospinal fluid

    Recruiting
    • Lung Cancer
    • +5 more
    • Stereotactic Radiosurgery
    • Cerebrospinal fluid collection
    • Basking Ridge, New Jersey
    • +6 more
    Nov 11, 2022

    Lung Cancer, Small-cell Lung Cancer Trial in Lebanon (Trilaciclib, Lurbinectedin)

    Recruiting
    • Lung Cancer
    • Small-cell Lung Cancer
    • Lebanon, New Hampshire
      Dartmouth Hitchcock Medical Center
    Nov 9, 2022

    DOTATOC PET/CT for Imaging NET Patients

    Recruiting
    • Neuroendocrine Tumors
    • +15 more
    • 68Ga-DOTATOC PET/CT
    • 18F-FDG PET/CT
    • Vancouver, British Columbia, Canada
      BC Cancer
    Nov 2, 2022

    Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer Trial in Kissimmee, Tampa (Nivolumab,

    Recruiting
    • Small-cell Lung Cancer
    • +2 more
    • Kissimmee, Florida
    • +1 more
    Nov 2, 2022

    Gastric Cancer, Small-cell Lung Cancer Trial in China, Korea, Republic of, Taiwan (EP0057, Olaparib tablets)

    Not yet recruiting
    • Gastric Cancer
    • Small-cell Lung Cancer
    • Shanghai, Changning District, 交通大学 邮政编码, China
    • +20 more
    Nov 1, 2022

    Small-cell Lung Cancer, Brain Metastases Trial in United States (Carboplatin, Etoposide, Atezolizumab)

    Active, not recruiting
    • Small-cell Lung Cancer
    • Brain Metastases
    • Duarte, California
    • +5 more
    Oct 10, 2022

    Thymic Carcinoma, NSCLC, Refractory Thoracic Tumors Trial in United States (VEGFR/PDGFR Dual Kinase Inhibitor X-82, Nivolumab)

    Active, not recruiting
    • Thymic Carcinoma
    • +3 more
    • VEGFR/PDGFR Dual Kinase Inhibitor X-82
    • Nivolumab
    • Palo Alto, California
    • +6 more
    Sep 21, 2022

    Small-cell Lung Cancer Trial in Shanghai (thoracic radiotherapy)

    Recruiting
    • Small-cell Lung Cancer
    • thoracic radiotherapy
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai jiaotong univestigy school of medicine
    Sep 21, 2022

    Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in United States (Olaparib Pill 50 mg, Olaparib Pill 100 mg, Olaparib

    Active, not recruiting
    • Small-cell Lung Cancer
    • Small Cell Lung Carcinoma
    • Olaparib Pill 50 mg
    • +6 more
    • Miami, Florida
    • +8 more
    Sep 14, 2022

    Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer Trial in United States (SY-5609, Fulvestrant, Gemcitabine)

    Recruiting
    • Advanced Solid Tumor
    • +3 more
    • Gilbert, Arizona
    • +16 more
    Sep 13, 2022

    Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

    Recruiting
    • Melanoma
    • +14 more
    • LITT + Pembrolizumab
    • Gainesville, Florida
    • +1 more
    Aug 22, 2022

    Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial in United Kingdom, United States

    Terminated
    • Pancreatic Adenocarcinoma
    • +13 more
    • San Francisco, California
    • +7 more
    Aug 17, 2022

    Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Pittsburgh (Onvansertib)

    Recruiting
    • Small-cell Lung Cancer
    • Small Cell Lung Carcinoma
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jul 29, 2022

    Small-cell Lung Cancer Trial in Canton (Chiauranib)

    Recruiting
    • Small-cell Lung Cancer
    • Canton, Ohio
      Gabrail Cancer Center Research
    Jul 27, 2022

    Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)

    Recruiting
    • Metastatic Non-small Cell Lung Cancer (NSCLC)
    • +5 more
    • data collection
    • Oldenburg, Germany
      Pius-Hospital
    Jul 20, 2022